1. Stanford, JL, Terencio de las Aguas, J, Torres, P, Gervasioni, BO, Ravioli, R, Studies on the effects of a potential immunotherapeutic agent in leprosy patients, Health Cooperation Papers 1987; 7: Proceedings of the Fourth European Leprosy Symposium: 201–206
2. Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis;Stanford;Vaccine,1990
3. Leprosy vaccines;Young,1991
4. Evaluation of adjunct immunotherapy with killed Mycobacterium vaccae in the treatment of multibacillary leprosy and erythema nodosum leprosum;Ramu,1998
5. Berwanger, CS, Ingledew, NB, Shukla, N, et al., Heat shock protein 65 increases arterial contractility which can be reversed with Mycobacterium vaccae, Proceedings of the International meeting on Heat Shock Proteins, Connecticut, 1998